0001562180-19-006296.txt : 20191231 0001562180-19-006296.hdr.sgml : 20191231 20191231193317 ACCESSION NUMBER: 0001562180-19-006296 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191230 FILED AS OF DATE: 20191231 DATE AS OF CHANGE: 20191231 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Berman Robert CENTRAL INDEX KEY: 0001704483 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38080 FILM NUMBER: 191320358 MAIL ADDRESS: STREET 1: C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP STREET 2: 234 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd. CENTRAL INDEX KEY: 0001689813 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 203-404-0410 MAIL ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2019-12-30 false 0001689813 Biohaven Pharmaceutical Holding Co Ltd. BHVN 0001704483 Berman Robert C/O BIOHAVEN PHARMACEUTICALS, INC. 215 CHURCH STREET NEW HAVEN CT 06510 false true false false Special Projects & Med Ovrsght Common Shares 2019-12-30 4 M false 125000.00 0.61 A 125341.00 D Common Shares 2019-12-30 4 S false 67450.00 52.9481 D 57891.00 D Common Shares 2019-12-30 4 S false 53762.00 53.429 D 4129.00 D Common Shares 2019-12-30 4 S false 3488.00 54.8917 D 641.00 D Common Shares 2019-12-30 4 S false 300.00 55.97 D 341.00 D Common Shares 550000.00 I By Berman Family Trust 2013 Common Shares 240500.00 I By Berman Marital Trust 2013 Common Shares 50.00 I Owned by Spouse Employee Stock Option (right to buy) 0.61 2019-12-30 4 M false 125000.00 0.00 D 2024-11-25 Common Shares 125000.00 100000.00 D These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.23 - $53.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.23 - $53.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.64 - $55.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. The option, representing a right to purchase a total of 225,000 shares, was granted on November 26, 2014, and vested in four equal installments on November 26, 2014, 2015, 2016 and 2017 /s/ Jim Engelhart, Attorney-in-Fact 2019-12-31